Literature DB >> 24639333

Treatment of trivalvular rheumatic heart disease: why it matters where we live.

Mairead Christine Kelly1, Robert Jennings, Matthew Heron.   

Abstract

A 42-year-old woman who had recently emigrated to the UK from Ethiopia presented to her general practitioner with increasing breathlessness and palpitations. Transoesophageal echocardiogram revealed rheumatic heart disease affecting three valves, and severe aortic stenosis. ECG demonstrated atrial fibrillation. She was treated operatively with mitral and aortic valve replacement and tricuspid valve repair and put on lifelong warfarin. Four months later she remains well, with substantially increased exercise tolerance. This case report summarises treatment options for severe rheumatic heart disease and discusses differences in prevention and management between patients presenting in the UK and in the developing world.

Entities:  

Mesh:

Year:  2014        PMID: 24639333      PMCID: PMC3962854          DOI: 10.1136/bcr-2013-202006

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

Review 1.  Choice of heart valve prosthesis.

Authors:  Peter Bloomfield
Journal:  Heart       Date:  2002-06       Impact factor: 5.994

Review 2.  Rheumatic heart disease.

Authors:  Eloi Marijon; Mariana Mirabel; David S Celermajer; Xavier Jouven
Journal:  Lancet       Date:  2012-03-10       Impact factor: 79.321

3.  Short- and mid-term results of triple-valve surgery with an evaluation of postoperative quality of life.

Authors:  Saeed Davoodi; Abbasali Karimi; Seyed Hossein Ahmadi; Mehrab Marzban; Namvar Movahhedi; Kyomars Abbasi; Abbas Salehi Omran; Mahmood Shirzad; Mehrdad Sheikhvatan
Journal:  Tex Heart Inst J       Date:  2009

Review 4.  Rheumatic heart disease in indigenous populations.

Authors:  Harvey White; Warren Walsh; Alex Brown; Tania Riddell; Andrew Tonkin; Richmond Jeremy; David Brieger; Chris Zeitz; Leonard Kritharides
Journal:  Heart Lung Circ       Date:  2010-03-30       Impact factor: 2.975

5.  Assessment of a register-based rheumatic heart disease secondary prevention program in an Australian Aboriginal community.

Authors:  Sabry Eissa; Rosemary Lee; Philippa Binns; Gaynor Garstone; Malcolm McDonald
Journal:  Aust N Z J Public Health       Date:  2005-12       Impact factor: 2.939

6.  Is primary prevention of rheumatic fever the missing link in the control of rheumatic heart disease in Africa?

Authors:  Ganesan Karthikeyan; Bongani M Mayosi
Journal:  Circulation       Date:  2009-08-10       Impact factor: 29.690

7.  Triple-valve surgery: clinical results of a three-decade experience.

Authors:  Guillaume Marquis Gravel; Denis Bouchard; Louis P Perrault; Pierre Pagé; Michel Carrier; Raymond Cartier; Hugues Jeanmart; Michel Pellerin
Journal:  J Heart Valve Dis       Date:  2011-01

8.  Triple valve repair for rheumatic heart disease.

Authors:  John P Liuzzo; Yong T Shin; Richard Lucariello; Marc Klapholz; Samuel J Lang; Robert Braff; Hui Guan; John T Coppola; John A Ambrose
Journal:  J Card Surg       Date:  2005 Jul-Aug       Impact factor: 1.620

9.  Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.